0000000000611206

AUTHOR

Mark Kosinski

showing 1 related works from this author

Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD

2017

Objective: To assess relationships between treatment-associated changes in measures of ADHD symptoms, functional impairments, and health-related quality of life in children and adolescents with ADHD. Method: Pearson correlation coefficients were calculated post hoc for changes from baseline to endpoint in outcomes of one randomized, placebo- and active-controlled trial of lisdexamfetamine (osmotic-release methylphenidate reference) and one of guanfacine extended-release (atomoxetine reference). Results: Changes in ADHD Rating Scale IV (ADHD-RS-IV) total score generally correlated moderately with changes in Child Health and Illness Profile−Child Edition: Parent Report Form (CHIP-CE:PRF) Ach…

CHIP-CEmedicine.medical_specialtyFunctional impairmentLisdexamfetamine DimesylateHRQoL03 medical and health sciences0302 clinical medicineQuality of life (healthcare)pharmacological treatmentDevelopmental and Educational PsychologymedicineAttention deficit hyperactivity disorderADHD0501 psychology and cognitive sciencesAdhd symptomsPsychiatry05 social sciencesAtomoxetineArticlesmedicine.diseaseClinical trialClinical Psychologyfunctional impairmentExtended releasePsychology030217 neurology & neurosurgery050104 developmental & child psychologymedicine.drugJournal of Attention Disorders
researchProduct